Low-dose anti-thymocyte globulin preserves C-peptide, reduces HbA 1c , and increases regulatory to conventional T-cell ratios in new-onset type 1 diabetes: two-year clinical trial data
Contains gelatine (animal origin)
Semaglutide and Body Composition (12-Month Prospective Study) van Baak MA, Brakema EA, Wijngaarden M van der, et al
Since both options are providing the same core molecule, the "better" choice usually comes down to the formulation and your personal values regarding ingredients
So, I dont think were going to be held ransom to one single disorder
April 23 Product: Day One Biopharmaceuticals Ojemda Indication: Pediatric low-grade glioma The FDA has approved the first medicine for children with relapsed or refractory pediatric low-grade glioma (pLGG) with BRAF fusions or rearrangements, Day One Biopharmaceuticals announced Tuesday